Current evidence demonstrates that suppression of eIF4E2 via lentiviral-delivered shRNAs is effective at stalling or reversing tumor growth in mouse xenografts of several different cancer cell lines [22] (Figure 2(b)). The gene discussed is EIF4E2; the disease is neoplasm.